BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28754616)

  • 1. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease.
    Gao H; Liu S
    Life Sci; 2017 Sep; 185():23-29. PubMed ID: 28754616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant.
    Miyamoto Y; Watanabe H; Otagiri M; Maruyama T
    Ther Apher Dial; 2011 Apr; 15(2):129-31. PubMed ID: 21426502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
    Fujii H; Nakai K; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic toxicity of indoxyl sulfate.
    Niwa T
    Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access.
    Wu CC; Hung SC; Kuo KL; Tarng DC
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28067862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoxyl sulfate is a nephro-vascular toxin.
    Niwa T
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G; Burtey S; Sallée M
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].
    Kiss I
    Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
    Watanabe H
    Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease.
    Lin CJ; Liu HL; Pan CF; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2012 Aug; 43(6):451-6. PubMed ID: 22885091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress of the uremic toxin indoxyl sulfate in cardiovascular complication of end-stage renal diseases].
    Guo CC; Xia WW; Zhang AH
    Sheng Li Xue Bao; 2018 Dec; 70(6):657-662. PubMed ID: 30560276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
    Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis.
    Tan X; Cao X; Zou J; Shen B; Zhang X; Liu Z; Lv W; Teng J; Ding X
    Hemodial Int; 2017 Apr; 21(2):161-167. PubMed ID: 27616754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis.
    Wakamatsu T; Yamamoto S; Yoshida S; Narita I
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease.
    Hung SC; Kuo KL; Wu CC; Tarng DC
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28174171
    [No Abstract]   [Full Text] [Related]  

  • 19. Indoxyl sulfate induces complex redox alterations in mesangial cells.
    Gelasco AK; Raymond JR
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1551-8. PubMed ID: 16434574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of carbon adsorbent in the conservative management of chronic kidney disease.
    Niwa T
    Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.